Primary healthcare providers in the Netherlands are evaluating a new tool aimed at enhancing the management of chronic conditions. The Assessment of Burden of Chronic Conditions (ABCC) tool, designed to facilitate personalized care, was integrated into routine consultations to support patients with multiple chronic diseases such as COPD, asthma, type 2 diabetes, and chronic heart failure.
Study Overview and Methodology
Conducted over an 18-month period, the study involved 231 participants divided into an intervention group and a control group receiving standard care. The research focused on assessing the cost-effectiveness of the ABCC tool by measuring quality-adjusted life years (QALYs) and associated healthcare costs. Various sensitivity analyses were performed to account for different perspectives and potential disruptions, including those caused by the COVID-19 pandemic.
Key Findings and Economic Implications
The introduction of the ABCC tool resulted in higher costs but also improved health outcomes compared to usual care. The initial analysis revealed an incremental cost-effectiveness ratio (ICER) of €64,525 per QALY, with a 29% probability of being cost-effective. However, sensitivity analyses provided more optimistic results, suggesting higher probabilities of cost-effectiveness under different scenarios.
• ABCC tool demonstrated increased effectiveness in managing chronic conditions.
• Initial costs are higher, but improved patient outcomes present long-term benefits.
• Sensitivity analyses indicate varying degrees of cost-effectiveness depending on the perspective.
• Per-protocol analysis suggests potential cost savings when the tool is consistently used.
While the primary analysis presents a modest probability of cost-effectiveness, the additional sensitivity analyses highlight scenarios where the ABCC tool could provide significant economic advantages. This suggests that the tool’s integration into primary care settings may yield better financial and health outcomes, particularly when employed diligently.
Implementing the ABCC tool could represent a strategic investment for healthcare systems facing the growing challenge of chronic disease management. By enabling more personalized and efficient care, the tool has the potential to enhance patient quality of life and streamline healthcare resources. Future studies should explore long-term impacts and broader applications across different healthcare environments to fully understand the tool’s benefits and optimize its implementation.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
